RxDoctor Payments Data

Donald Tashkin

Pulmonary Disease · Los Angeles, CANPI 1528088135

Payments from drug & device makers

$141,364in general payments, 2019–2025

Across 161 payments — averaging $878.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mylan Specialty L.p.$54K
  • Boehringer Ingelheim$28K
  • Merck$18K
  • AstraZeneca$15K
  • Mylan Inc.$14K
  • Sunovion Pharmaceuticals Inc.$8K
  • plus $4K from 4 others

What the payments were for

  • Consulting fees$46,31433%
  • Speaking & faculty fees$82,40658%
  • Travel & lodging$9,7367%
  • Food & beverage$2,9072%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$141,364 in reported general payments places this provider in the 90th percentile of 1,261 pulmonary disease providers in California.

See all pulmonary disease providers in California

Other pulmonary disease in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →